13F

AUTL AUTOLUS THERAPEUTICS PLC

2026Q1 · CUSIP 05280R100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
83
Δ holders QoQ
-6
Breadth percentile
Top 80%
Whale holders
37
Δ whales
0
Inst. holding value
$183M
New positions
9
Closed positions
15
Price momentum (1Q)
+19.2%
Put / Call
0/3

Breadth history (34 quarters)

2018Q3: Δ-10 · h=40 2018Q4: Δ-1 · h=39 2019Q1: Δ-2 · h=37 2019Q2: Δ+11 · h=48 2019Q3: Δ-2 · h=46 2019Q4: Δ+12 · h=58 2020Q1: Δ-4 · h=54 2020Q2: Δ-3 · h=51 2020Q3: Δ-3 · h=48 2020Q4: Δ+1 · h=49 2021Q1: Δ+14 · h=63 2021Q2: Δ+7 · h=70 2021Q3: Δ-11 · h=59 2021Q4: Δ+15 · h=74 2022Q1: Δ-8 · h=66 2022Q2: Δ+2 · h=68 2022Q3: Δ-1 · h=67 2022Q4: Δ+6 · h=73 2023Q1: Δ-7 · h=66 2023Q2: Δ+3 · h=69 2023Q3: Δ+3 · h=72 2023Q4: Δ+28 · h=100 2024Q1: Δ+21 · h=121 2024Q2: Δ-9 · h=112 2024Q3: Δ-11 · h=101 2024Q4: Δ+9 · h=110 2025Q1: Δ-13 · h=97 2025Q2: Δ-2 · h=95 2025Q3: Δ+1 · h=96 2025Q4: Δ-7 · h=89 2026Q1: Δ-6 · h=83 2018Q3: holders=40 2018Q4: holders=39 2019Q1: holders=37 2019Q2: holders=48 2019Q3: holders=46 2019Q4: holders=58 2020Q1: holders=54 2020Q2: holders=51 2020Q3: holders=48 2020Q4: holders=49 2021Q1: holders=63 2021Q2: holders=70 2021Q3: holders=59 2021Q4: holders=74 2022Q1: holders=66 2022Q2: holders=68 2022Q3: holders=67 2022Q4: holders=73 2023Q1: holders=66 2023Q2: holders=69 2023Q3: holders=72 2023Q4: holders=100 2024Q1: holders=121 2024Q2: holders=112 2024Q3: holders=101 2024Q4: holders=110 2025Q1: holders=97 2025Q2: holders=95 2025Q3: holders=96 2025Q4: holders=89 2026Q1: holders=83 -28 -14 +0 +14 +28 3381128 18Q319Q220Q120Q421Q322Q223Q123Q424Q325Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q1 Top 14% -12.5% -29.8%
2023Q4 Top 19% -35.7% -43.8%
2019Q2 Top 13% +12.7% +3.0%

Options Sentiment

Put holders
0
QoQ: -1
Call holders
3
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.09
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
Quarterly Revenue & EPS (4Y)
2024-06-30: $0M 2024-09-30: $0M 2025-03-31: $9M 2025-06-30: $21M 2025-09-30: $21M 2025-12-31: $24M 2026-03-31: $26M 2023-03-31: EPS -0.23 2023-06-30: EPS -0.26 2023-09-30: EPS -0.26 2023-12-31: EPS -0.45 2024-03-31: EPS -0.24 2024-06-30: EPS -0.22 2024-09-30: EPS -0.31 2024-12-31: EPS -0.09 2025-03-31: EPS -0.26 2025-06-30: EPS -0.18 2025-09-30: EPS -0.30 2025-12-31: EPS -0.34 2026-03-31: EPS -0.27 0M 13M 26M $M -0.50 -0.25 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)